Susan E. Quaggin - 31 Dec 2025 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Susan E. Quaggin
Issuer symbol
ABBV
Transactions as of
31 Dec 2025
Net transactions value
+$15,537
Form type
4
Filing time
05 Jan 2026, 17:00:15 UTC
Previous filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Quaggin Susan E Director 1 N. WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, Attorney-in-Fact for Susan E. Quaggin 05 Jan 2026 0001997505

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Stock Equivalent Units Award $15,537 +68 +11% $228.49 707 31 Dec 2025 Common Stock 68 $228.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.